Drug resistance

WHO Global Strategy Recommendations

Fundamental priority recommendations are underlined and highlighted in bold
Other first priority recommendations are highlighted in bold.


Hospitals

Management

3.1 Establish infection control programmes, based on current best practice, with the responsibility for effective management of antimicrobial resistance in hospitals and ensure that all hospitals have access to such a programme.

3.2 Establish effective hospital therapeutics committees with the responsibility for overseeing antimicrobial use in hospitals. environment and ensure that such activities have educational benefit.

3.3 Develop and regularly update guidelines for antimicrobial treatment and prophylaxis, and hospital antimicrobial formularies.

3.4 Monitor antimicrobial usage, including the quantity and patterns of use, and feedback results to prescribers. Diagnostic laboratories

3.5 Ensure access to microbiology laboratory services that match the level of the hospital, e.g. secondary, tertiary.l

3.6 Ensure performance and quality assurance of appropriate diagnostic tests, microbial identification, antimicrobial susceptibility tests of key pathogens, and timely and relevant reporting of results.

3.7 Ensure that laboratory data are recorded, preferably on a database, and are used to produce clinically- and epidemiologically-useful surveillance reports of resistance patterns among common pathogens and infections in a timely manner with feedback to prescribers and to the infection control programme.

Interactions with the pharmaceutical industry

3.8 Control and monitor pharmaceutical company promotional activities within the hospital

Share